RAC 2.20% $1.78 race oncology ltd

Ann: A$3m strategic investment from prominent biotech investors, page-16

  1. 114 Posts.
    lightbulb Created with Sketch. 14
    I'm pretty dissatisfied with this. These are all really great investors, however if management believe in their product do they need to sell RACES soul to get them onboard and have them sell it.

    I have held PNV since the beginning does it make me some kind of oracle, should I have been included in the raise.

    The original raise to Merchant was disappointing and this was........

    I would have supported a raise at the current share price and many posters said this also after the merchant raise.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.